# OnCo record nct04174599 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct04174599/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct04174599", "NCT04174599" ;
  schema:name "Study to Compare the Efficacy and Safety of F-627 and GRAN®"@en ;
  schema:description "A phase 3 trial of Efbemalenograstim alfa and Filgrastim in Breast cancer, run by EVIVE Biotechnology, completed."@en ;
  schema:url <https://onco.cc/trials/nct04174599/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04174599> ;
  onco:status "completed" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/breast-cancer/> ;
  onco:drugs <https://onco.cc/drugs/efbemalenograstim-alfa/>, <https://onco.cc/drugs/filgrastim/> ;
  onco:companies <https://onco.cc/companies/evive-biotech/> .